These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25264755)

  • 1. Hypoxic Vasospasm Mediated by cIMP: When Soluble Guanylyl Cyclase Turns Bad.
    Gao Y; Chen Z; Leung SW; Vanhoutte PM
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):545-8. PubMed ID: 25264755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cIMP synthesized by sGC as a mediator of hypoxic contraction of coronary arteries.
    Chen Z; Zhang X; Ying L; Dou D; Li Y; Bai Y; Liu J; Liu L; Feng H; Yu X; Leung SW; Vanhoutte PM; Gao Y
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H328-36. PubMed ID: 24906916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic augmentation: The tale of a strange contraction.
    Vanhoutte PM; Leung SWS
    Basic Clin Pharmacol Toxicol; 2020 Aug; 127(2):59-66. PubMed ID: 31310708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-derived NO, but not cyclic GMP, is required for hypoxic augmentation in isolated porcine coronary arteries.
    Chan CK; Mak J; Gao Y; Man RY; Vanhoutte PM
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2313-21. PubMed ID: 21984543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3',5'-cIMP as Potential Second Messenger in the Vascular Wall.
    Leung SWS; Gao Y; Vanhoutte PM
    Handb Exp Pharmacol; 2017; 238():209-228. PubMed ID: 26721675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDE1 or PDE5 inhibition augments NO-dependent hypoxic constriction of porcine coronary artery via elevating inosine 3',5'-cyclic monophosphate level.
    Nan Y; Zeng X; Jin Z; Li N; Chen Z; Chen J; Wang D; Wang Y; Lin Z; Ying L
    J Cell Mol Med; 2020 Dec; 24(24):14514-14524. PubMed ID: 33169529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissues cIMPly do not lie.
    Gao Y; Vanhoutte PM
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Sep; 387(9):901-3. PubMed ID: 25052042
    [No Abstract]   [Full Text] [Related]  

  • 8. Is cIMP a second messenger with functions opposite to those of cGMP?
    Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Sep; 387(9):897-9. PubMed ID: 25017018
    [No Abstract]   [Full Text] [Related]  

  • 9. cCMP, cUMP, cTMP, cIMP and cXMP as possible second messengers: development of a hypothesis based on studies with soluble guanylyl cyclase α(1)β(1).
    Beste KY; Seifert R
    Biol Chem; 2013 Feb; 394(2):261-70. PubMed ID: 23087103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-Dependent Contractions of Isolated Arteries to Thymoquinone Require Biased Activity of Soluble Guanylyl Cyclase with Subsequent Cyclic IMP Production.
    Detremmerie CM; Chen Z; Li Z; Alkharfy KM; Leung SW; Xu A; Gao Y; Vanhoutte PM
    J Pharmacol Exp Ther; 2016 Sep; 358(3):558-68. PubMed ID: 27335436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of NQO-1 mediates the augmented contractions of isolated arteries due to biased activity of soluble guanylyl cyclase in their smooth muscle.
    Detremmerie CMS; Leung SWS; Vanhoutte PM
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Nov; 391(11):1221-1235. PubMed ID: 30062552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction and vascular disease - a 30th anniversary update.
    Vanhoutte PM; Shimokawa H; Feletou M; Tang EH
    Acta Physiol (Oxf); 2017 Jan; 219(1):22-96. PubMed ID: 26706498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR.
    de Frutos S; Nitta CH; Caldwell E; Friedman J; González Bosc LV
    Am J Physiol Lung Cell Mol Physiol; 2009 Sep; 297(3):L475-86. PubMed ID: 19592461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional and Unconventional Mechanisms for Soluble Guanylyl Cyclase Signaling.
    Gao Y
    J Cardiovasc Pharmacol; 2016 May; 67(5):367-72. PubMed ID: 26452163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
    Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
    Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium nitrite causes relaxation of the isolated rat aorta: By stimulating both endothelial NO synthase and activating soluble guanylyl cyclase in vascular smooth muscle.
    Ling WC; Lau YS; Murugan DD; Vanhoutte PM; Mustafa MR
    Vascul Pharmacol; 2015 Nov; 74():87-92. PubMed ID: 26044183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
    Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
    Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A
    Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic hypoxia on soluble guanylate cyclase activity in fetal and adult ovine cerebral arteries.
    Pearce WJ; Williams JM; White CR; Lincoln TM
    J Appl Physiol (1985); 2009 Jul; 107(1):192-9. PubMed ID: 19407253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.
    Oka M; Karoor V; Homma N; Nagaoka T; Sakao E; Golembeski SM; Limbird J; Imamura M; Gebb SA; Fagan KA; McMurtry IF
    Cardiovasc Res; 2007 Jun; 74(3):377-87. PubMed ID: 17346686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.